Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens Kuhle

Showing results (1-10 of 486) with videos related to

Pageof 49
Sort By:
Neurology|September 2, 2016
Comment: "If you can't measure it, you can't improve it" (Lord Kelvin)Jens Kuhle
Expert Opinion on Medical Diagnostics|March 15, 2013
What makes a prognostic biomarker in CNS diseases: strategies for targeted biomarker discovery? Part 1: acute and monophasic diseasesJens Kuhle, Axel Petzold
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 19, 2019
Serum NfL levels should be used to monitor multiple sclerosis evolution - YesDavid Leppert, Jens Kuhle
Expert Opinion on Medical Diagnostics|March 15, 2013
What makes a prognostic biomarker in CNS diseases: strategies for targeted biomarker discovery? Part 2: chronic progressive and relapsing diseaseJens Kuhle, Axel Petzold
Neurology(R) Neuroimmunology & Neuroinflammation|September 14, 2019
Blood neurofilament light chain at the doorstep of clinical applicationDavid Leppert, Jens Kuhle
Annals of Neurology|May 27, 2021
Reply to: Neurofilament Light Chain in Patients with COVID-19 and Bacterial PneumoniaDavid Leppert, Raoul Sutter, Jens Kuhle
The Neurologist|January 16, 2008
10 most commonly asked questions about cerebrospinal fluid characteristics in demyelinating disorders of the central nervous systemMatthias Mehling, Jens Kuhle, Axel Regeniter
Neurology(R) Neuroimmunology & Neuroinflammation|August 18, 2020
Lymphocyte recovery after fingolimod discontinuation in patients with MSSara Nagy, Jens Kuhle, Tobias Derfuss
Frontiers in Neurology|July 28, 2022
Case Report: A 72-Year-Old Woman With Progressive Motor Weakness, Dry Eyes and High Levels of Serum Neurofilament Light ChainMaria Janina Wendebourg, Jens Kuhle, Martin Hardmeier
JAMA Neurology|April 3, 2023
Challenges and Opportunities for the Promising Biomarker Blood Neurofilament Light ChainAhmed Abdelhak, Jens Kuhle, Ari J Green
Pageof 49

Showing results (1-10 of 486) with videos related to

Sort By:
Pageof 49
Neurology|September 2, 2016
Comment: "If you can't measure it, you can't improve it" (Lord Kelvin)Jens Kuhle
Expert Opinion on Medical Diagnostics|March 15, 2013
What makes a prognostic biomarker in CNS diseases: strategies for targeted biomarker discovery? Part 1: acute and monophasic diseasesJens Kuhle, Axel Petzold
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 19, 2019
Serum NfL levels should be used to monitor multiple sclerosis evolution - YesDavid Leppert, Jens Kuhle
Expert Opinion on Medical Diagnostics|March 15, 2013
What makes a prognostic biomarker in CNS diseases: strategies for targeted biomarker discovery? Part 2: chronic progressive and relapsing diseaseJens Kuhle, Axel Petzold
Neurology(R) Neuroimmunology & Neuroinflammation|September 14, 2019
Blood neurofilament light chain at the doorstep of clinical applicationDavid Leppert, Jens Kuhle
Annals of Neurology|May 27, 2021
Reply to: Neurofilament Light Chain in Patients with COVID-19 and Bacterial PneumoniaDavid Leppert, Raoul Sutter, Jens Kuhle
The Neurologist|January 16, 2008
10 most commonly asked questions about cerebrospinal fluid characteristics in demyelinating disorders of the central nervous systemMatthias Mehling, Jens Kuhle, Axel Regeniter
Neurology(R) Neuroimmunology & Neuroinflammation|August 18, 2020
Lymphocyte recovery after fingolimod discontinuation in patients with MSSara Nagy, Jens Kuhle, Tobias Derfuss
Frontiers in Neurology|July 28, 2022
Case Report: A 72-Year-Old Woman With Progressive Motor Weakness, Dry Eyes and High Levels of Serum Neurofilament Light ChainMaria Janina Wendebourg, Jens Kuhle, Martin Hardmeier
JAMA Neurology|April 3, 2023
Challenges and Opportunities for the Promising Biomarker Blood Neurofilament Light ChainAhmed Abdelhak, Jens Kuhle, Ari J Green
Pageof 49